KYTX investors have the opportunity to participate in the securities fraud investigation at Kyverna Therapeutics, Inc.

LOS ANGELES, June 14, 2024 /PRNewswire/ – The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims of violations of the securities laws on behalf of investors in Kyverna Therapeutics, Inc. (“Kyverna” or “the Company”) (NASDAQ: KYTX).

The investigation focuses on whether the company made false and/or misleading statements and/or failed to disclose relevant information to investors. Kyverna is the subject of a I’m looking for Alpha Report published on June 14, 2024According to the article, “Kyverna (NASDAQ:KYTX) shares plunged 28% on Friday morning following a presentation that included updated data on its lead CAR-T cell therapy candidate, KYV-101.” Kyverna shares lost more than 35% by early afternoon of the same day.

If you are a shareholder who has suffered a loss, click here to participate.

We also recommend that you contact Brian Schall the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, California 90067, 310-301-3335 to discuss your rights free of charge. You may also contact us through the Firm’s website at www.schallfirm.com or by email at (email protected).

The Schall Law Firm represents investors throughout the world and specializes in securities class action litigation and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under applicable laws and professional rules.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
(email protected)
www.schallfirm.com

Never miss a story from The Schall Law Firm again.